Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Feb;98(2):264-271.
doi: 10.1002/ajh.26785. Epub 2023 Jan 1.

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study

Affiliations
Multicenter Study

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study

Charles Dumontet et al. Am J Hematol. 2023 Feb.

Abstract

Familial forms of monoclonal gammopathy, defined as multiple myeloma (MM) or Monoclonal Gammopathy of Undetermined Significance (MGUS), are relatively infrequent and most series reported in the literature describe a limited number of families. MM rarely occurs in a familial context. MGUS is observed much more commonly, which can in some cases evolve toward full-blown MM. Although recurrent cytogenetic abnormalities have been described in tumor cells of sporadic cases of MM, the pathogenesis of familial MM remains largely unexplained. In order to identify genetic factors predisposing to familial monoclonal gammopathy, the Intergroupe Francophone du Myélome identified 318 families with at least two confirmed cases of monoclonal gammopathy. There were 169 families with parent/child pairs and 164 families with cases in at least two siblings, compatible with an autosomal transmission. These familial cases were compared with sporadic cases who were matched for age at diagnosis, sex and immunoglobulin isotype, with 10 sporadic cases for each familial case. The gender distribution, age and immunoglobulin subtypes of familial cases were unremarkable in comparison to sporadic cases. With a median follow-up of 7.4 years after diagnosis, the percentage of MGUS cases having evolved to MM was 3%. The median overall survival of the 148 familial MM cases was longer than that of matched sporadic cases, with projected values of 7.6 and 16.1 years in patients older and younger than 65 years, respectively. These data suggest that familial cases of monoclonal gammopathy are similar to sporadic cases in terms of clinical presentation and carry a better prognosis.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any disclosures.

Figures

FIGURE 1
FIGURE 1
Overall survival curves of the 148 patients with familial forms of multiple myeloma (MM) and the 1480 case‐matched sporadic controls with MM. (A) All patients, (B) according to age. [Color figure can be viewed at wileyonlinelibrary.com]

References

    1. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ 3rd. Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer. 2004;101(11):2667‐2674. - PubMed
    1. Dumontet C, Couray‐Targe S, Teisseire M, Karlin L, Maucort‐Boulch D. Real life management of patients hospitalized with multiple myeloma in France. PLoS One. 2018;13(5):e0196596. - PMC - PubMed
    1. Kristinsson SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of lymphoproliferative disorders among first‐degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population‐based study in Sweden. Blood. 2008;112(8):3052‐3056. - PMC - PubMed
    1. Schinasi LH, Brown EE, Camp NJ, et al. Multiple myeloma and family history of lymphohaematopoietic cancers: results from the international multiple myeloma consortium. Br J Haematol. 2016;175(1):87‐101. - PMC - PubMed
    1. Vachon CM, Kyle RA, Therneau TM, et al. Increased risk of monoclonal gammopathy in first‐degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood. 2009;114(4):785‐790. - PMC - PubMed

Publication types

LinkOut - more resources